Rheumatology Drug Updates: Biosiomilar to Adalimumab Receives FDA Approval; plus Updates on Baricitinib, Tofacitinib, Bimekizumab
FDA Responds to New Drug Application for Baricitinib
Biosimilar Drugs Raise Questions around Treatment Efficacy, Quality, Safety
Quality Measures Used to Assess Care, Improve Outcomes in Children, Adults with Rheumatic Diseases
Pain Management Research Sheds Light on Postsurgical Pain Sensitization, Opioid Risks, Nondrug Interventions
Rheumatology Practices Need Sharp Focus on Patient Care Safety, Quality
Tips for Rheumatologists to Master Quality Measurement in Clinical Practice
The ACR’s 2015 Workforce Study Reveals Gap Between Rheumatologist Supply, Patient Demand
Combining Humanities, Clinical Care Essential to Providing Quality Healthcare
- 1
- 2
- 3
- …
- 9
- Next Page »